Scientific Program
| October 21(Mon) 08:30-10:10 |
Symposium 3 Host-Microbiota Interaction |
Room A | ||
|---|---|---|---|---|
| Speaker(s) |
Wild-derived microbiota regulate host immune responses and disease outcome in preclinical models
Barbara Rehermann (NIH, USA) |
|||
|
Microbiome Therapeutics for Inflammatory Disorders and Cancer
Sin-Hyeog Im (POSTECH, KOR) |
||||
| October 21(Mon) 08:30-10:10 |
Symposium 4 B cell and Cytokines |
Room B | ||
|---|---|---|---|---|
| Speaker(s) |
IL-4 and germinal center B cell selection
Marion Pepper (Univ. of Washington, USA) |
|||
|
Title: B cell immune responses in complex microenvironment
Ziv Shulman (Weizmann Institute of Science, ISR) |
||||
|
The impact of type I interferon dynamics on memory B cell subsets during infection
Kim Good-Jacobson (Monash Univ., AUS) |
||||
| October 21(Mon) 08:30-10:10 |
Symposium 5 KAI-AKIA |
Room C | ||
|---|---|---|---|---|
| Speaker(s) |
Dissecting host immune responses in situ
Jun Huh (Harvard Univ., USA) |
|||
|
CD103 preconditions naïve CD8 T cells for their acquisition of effector phenotype and function
Jung-Hyun Park (NIH/NCI, USA) |
||||
|
TBC
|
||||
|
TBC
|
||||
| October 21(Mon) 10:40-12:00 |
Symposium 6 Trained Immunity and Cytokines |
Room A | ||
|---|---|---|---|---|
| Speaker(s) |
Central Trained Immunity and Chronic Inflammation
George Hajishengallis (Univ. of Pennsylvania, USA) |
|||
|
Innate Immune Memory and the Aging Eye
Przemyslaw Sapieha (Centre de recherche HMR, FRA) |
||||
| October 21(Mon) 10:40-12:00 |
Symposium 7 Mucosal Immunity |
Room B | ||
|---|---|---|---|---|
| Speaker(s) |
Microbiota-regulation of Tumor-Associated Macrophages
Jorge Henao-Mejia (Univ. of Pennsylvania, USA) |
|||
|
Microbiota and immune responses in the stomach are involved in controlling various diseases
Naoko Satoh-Takayama (RIKEN, JPN) |
||||
| October 21(Mon) 10:40-12:00 |
Symposium 8 T cell Homeostasis and Cytokines (Charles D. Surh Memorial Session) |
Room C | ||
|---|---|---|---|---|
| Speaker(s) |
Fixing to generate new T cells (lessons learned from Charlie Surh, about golf, wine & cytokines)
Juan Carlos Zuniga-Pflucker (Univ. of Toronto, CAN) |
|||
|
Subsetting and shaping naive CD8 T cell pools with complex effector codes
Jae Ho Cho (Chonnam Univ, KOR) |
||||
| October 21(Mon) 16:20-18:00 |
Symposium 9 Tumor Immunology and Immunotherapy |
Room A | ||
|---|---|---|---|---|
| Speaker(s) |
Control of cytokine signaling to enhance efficacy and safety of CAR-T cell therapy
Yuki Kagoya (Keio Univ., JPN) |
|||
|
Shared mechanisms of Anti-PD1 efficacy in tumor, and toxicity in tissue
Niroshana Anandasabapathy (Cornell Univ., USA) |
||||
|
Functional Identification and Therapeutic Targeting of Cancer Neoantigens
Stephen Schoenberger (La Jolla Institute for Immunology, USA) |
||||
| October 21(Mon) 16:20-18:00 |
Symposium 10 Infection and Immunity |
Room B | ||
|---|---|---|---|---|
| Speaker(s) |
Differential innate antiviral signaling in human and bat cells
Karen Mossman (McMaster Univ., CAN) |
|||
|
Inflammasome sensing in inflammation and cancer
Si Ming Man (Australia National Univ., AUS) |
||||
|
Regulation of IL-15-induced NK-like activation of CD8+ T cells in viral infection
Eui-Cheol Shin (KAIST, KOR) |
||||
| October 21(Mon) 16:20-18:00 |
Guest Symposium Predicting virus associated inflammatory disease severity in children with laboratory diagnostics and artificial intelligence- PreVAIL kIds experience with SARS-CoV-2 infection syndrome including MIS-C |
Room C | ||
|---|---|---|---|---|
| Speaker(s) |
Analytics approaches to evaluate the contribution of biomarkers integrated into clinical prediction models
Cedric Manlhiot (Johns Hopkins University, USA) |
|||
|
ML derived unique cytokine/chemokine biosignature of MIS-C across SARS-CoV-2 variants
Ananth Annapragada (Texas Children's Hospital, USA) |
||||
|
Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)
Juan Salazar (Connecticut Children's Hospital, USA) |
||||
|
Multisystem inflammatory syndrome in children (MIS-C) induces a Toll-like receptor-tolerant phenotype in peripheral blood cells that is genetically modulated
Maria Gennaro (Rutgers University, USA) |
||||
|
Diagnosing and predicting risk in children with SARS-CoV-2 related illness
Jane Burns (University of California, San Diego, USA) |
||||
|
Host-based clinical assays for diagnosis and severity prediction of COVID-19 associated clinical syndromes including MIS-C
Charles Chiu (University of California, San Francisco, USA) |
||||
- Cytokines 2024 & KAI 2024 Secretariat
- Hosted by
-
-
- 사단법인 대한면역학회 (대표자 : 이상일)
- 사업자등록번호 : 106-82-14623
- 서울시 강남구 테헤란로7길 22, 한국과학기술회관 1관 11층 1103
- Tel: 02-797-0975
Copyright ⓒ Cytokines 2024 & KAI 2024 Secretariat. All Rights Reserved.